Nature Communications (Apr 2022)
Structural basis for PoxtA-mediated resistance to phenicol and oxazolidinone antibiotics
Abstract
PoxtA confers resistance to ribosome-targeting oxazolidinone (linezolid) and chloramphenicol antibiotics. Here, Crowe-McAuliffe et al. provide structural insights into how binding of PoxtA to the ribosome indirectly promotes drug dissociation.